Szczegółowy przewodnik wkrótce
Pracujemy nad kompleksowym przewodnikiem edukacyjnym dla Wells Score for Pulmonary Embolism. Wróć wkrótce po wyjaśnienia krok po kroku, wzory, przykłady z życia i porady ekspertów.
The Wells Score for Pulmonary Embolism (PE) is a validated clinical decision rule used to estimate the pre-test probability that a patient is suffering from acute pulmonary embolism. Developed by Dr. Philip Wells and colleagues and first published in 2000, the score assigns weighted points to seven clinical variables that reflect the patient's history, symptoms, signs, and the clinician's overall judgement. The resulting total stratifies patients into risk categories — either a two-level system (PE unlikely vs. PE likely) or a three-level system (low, moderate, and high probability) — which then determines the most appropriate next diagnostic step. Pulmonary embolism is a potentially life-threatening condition caused by obstruction of one or more pulmonary arteries, most often by a thrombus originating in the deep veins of the legs (deep vein thrombosis, DVT). Because the clinical presentation of PE is highly variable — ranging from mild exertional dyspnoea to haemodynamic collapse — and because its symptoms overlap with many other conditions such as pneumonia, musculoskeletal chest pain, and anxiety, objective pre-test probability assessment is essential before initiating imaging or empirical anticoagulation. The Wells PE score is incorporated into international guidelines including the European Society of Cardiology (ESC) 2019 guidelines on the diagnosis and management of acute pulmonary embolism. The two-level classification is particularly powerful because it enables a safe rule-out pathway: patients with a Wells score of 4 or less (PE unlikely) who also have a negative high-sensitivity D-dimer assay can have PE safely excluded without the radiation exposure of CT pulmonary angiography (CTPA). Conversely, patients with a score greater than 4 (PE likely) should proceed directly to CTPA. The score has been validated in multiple large prospective multicentre cohorts across emergency department and outpatient settings, demonstrating robust sensitivity and specificity when combined with D-dimer testing. It remains one of the most widely taught and applied tools in acute medicine, emergency medicine, and respiratory medicine worldwide.
Wells Score for PE = sum of applicable criteria (0–12.5 points) • Clinical signs/symptoms of DVT (leg swelling, pain on deep palpation) → +3.0 points • PE is the #1 diagnosis, or equally likely → +3.0 points • Heart rate > 100 bpm → +1.5 points • Immobilisation ≥ 3 days OR surgery in previous 4 weeks → +1.5 points • Previous objectively confirmed DVT or PE → +1.5 points • Haemoptysis → +1.0 point • Malignancy (on treatment, treated in last 6 months, or palliative) → +1.0 point TWO-LEVEL CLASSIFICATION (most used in clinical practice): ≤ 4 points = PE unlikely → D-dimer testing; if negative, PE excluded > 4 points = PE likely → CT pulmonary angiography (CTPA) THREE-LEVEL CLASSIFICATION: < 2 points = Low probability (~10% PE prevalence) 2–6 points = Moderate probability (~30% PE prevalence) > 6 points = High probability (~65% PE prevalence) Age-adjusted D-dimer threshold (if PE unlikely): upper limit = age × 10 µg/L for patients ≥ 50 years
- 1Step 1 — Assess for clinical DVT signs: Examine the patient's legs for objective evidence of DVT — unilateral oedema, erythema, and deep tenderness along the femoral or popliteal vein distribution. If present, award 3 points. This is the highest-weighted criterion and reflects the dominant pathophysiology of venothromboembolic disease.
- 2Step 2 — Apply clinical gestalt: The clinician must make a global assessment of whether PE is the most likely or equally likely diagnosis compared to all alternative explanations for the presentation. This subjective criterion (3 points) captures the value of expert clinical judgement and accounts for symptom constellations not fully captured by the other variables.
- 3Step 3 — Check heart rate: Record the resting heart rate. Tachycardia above 100 bpm is a physiological response to hypoxia and reduced cardiac output caused by PE-related right ventricular strain. Award 1.5 points if heart rate exceeds 100 bpm.
- 4Step 4 — Evaluate recent immobility or surgery: Ask specifically about bed rest or lower-limb immobility lasting 3 or more consecutive days, or any surgery under general or regional anaesthesia within the past 4 weeks. Both states promote venous stasis, a key component of Virchow's triad. Award 1.5 points if either applies.
- 5Step 5 — Review VTE history: Confirm any prior episode of DVT or PE that was diagnosed objectively (e.g., by ultrasound, venography, or CTPA). A history of VTE substantially raises the likelihood of recurrent disease. Award 1.5 points if confirmed.
- 6Step 6 — Assess for haemoptysis: Ask directly whether the patient has coughed up fresh or blood-streaked sputum. Haemoptysis occurs in PE due to pulmonary infarction and is an independent predictor. Award 1 point if present.
- 7Step 7 — Integrate D-dimer result after scoring: Once the total score is calculated, apply the two-level cut-off. If the score is 4 or less (PE unlikely), order a high-sensitivity D-dimer assay. A D-dimer below the age-adjusted threshold (for patients over 50: age × 10 mcg/L) safely excludes PE without CTPA. If the score exceeds 4 (PE likely), skip D-dimer and proceed directly to CTPA, as D-dimer cannot meaningfully lower post-test probability at high pre-test likelihood.
Score >4 mandates CTPA without D-dimer
PE most likely (3 pts) + tachycardia (1.5 pts) + prolonged immobility on flight (1.5 pts) = 6 points. CTPA is the appropriate next step. In this classic post-travel presentation, skipping D-dimer avoids false reassurance because pre-test probability is high.
Negative D-dimer would safely exclude PE
No criteria are met. The gradual onset, bilateral wheeze, and smoking history all favour a primary pulmonary cause such as COPD exacerbation or asthma. A high-sensitivity D-dimer should be ordered; if negative, PE can be excluded and workup redirected.
Maximum-risk profile — immediate CTPA and consider empirical anticoagulation
DVT signs (3) + PE most likely (3) + tachycardia (1.5) + recent hospitalisation (1.5) + haemoptysis (1) + active malignancy (1) = 11 points. This represents the highest-risk category. Given the haemodynamic status, empirical low-molecular-weight heparin should be considered while awaiting CTPA.
Order D-dimer; if elevated (expected post-operatively), proceed to CTPA
Recent surgery (1.5) + prior DVT (1.5) = 3 points. Although score is below 4, post-operative D-dimer is almost universally elevated due to surgical inflammation, making it non-informative. Clinical teams should consider that in the post-operative context D-dimer cannot rule out PE, and a low threshold for CTPA is appropriate if clinical suspicion persists.
Emergency department triage: Emergency physicians apply the Wells PE score at initial assessment to determine whether high-sensitivity D-dimer testing or immediate CTPA is appropriate, enabling rapid rule-out or confirmation of PE and reducing unnecessary radiation exposure.
Acute medical wards: Physicians managing acutely breathless or tachycardic inpatients use the Wells score to determine whether PE needs to be excluded before attributing symptoms to cardiac failure, pneumonia, or COPD exacerbation.
Pre-hospital and ambulance clinical decision support: Paramedics and advanced care practitioners in some health systems use the Wells score to pre-notify hospital teams about high-probability PE patients, enabling faster scanning on arrival.
Anticoagulation initiation decisions: In settings where CTPA is not immediately available (e.g., remote hospitals, out-of-hours), a high Wells score combined with clinical deterioration may support a decision to start empirical anticoagulation while awaiting imaging.
Quality and audit benchmarking: Hospital quality improvement teams use Wells score documentation rates as a process measure to assess compliance with PE diagnostic guidelines, and correlate score-guided management against clinical outcomes such as 30-day PE-related mortality and missed diagnoses.
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in wells pe calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in wells pe calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in wells pe calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in wells pe calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
In practice, this edge case requires careful consideration because standard assumptions may not hold. When encountering this scenario in wells pe calculations, practitioners should verify boundary conditions, check for division-by-zero risks, and consider whether the model's assumptions remain valid under these extreme conditions.
| Classification | Score | PE Prevalence | Recommended Action |
|---|---|---|---|
| PE Unlikely (2-level) | ≤ 4 points | ~12% | High-sensitivity D-dimer; if negative, PE excluded |
| PE Likely (2-level) | > 4 points | ~30–40% | CT Pulmonary Angiography (CTPA) |
| Low probability (3-level) | < 2 points | ~1–3% | D-dimer; negative result highly reassuring |
| Moderate probability (3-level) | 2–6 points | ~16–28% | D-dimer; if positive, proceed to CTPA |
| High probability (3-level) | > 6 points | ~40–67% | Direct CTPA — skip D-dimer |
| Haemodynamic instability (any score) | Any | Up to 30% | Bedside echo, empirical thrombolysis if confirmed massive PE |
What is the Wells Score for pulmonary embolism?
The Wells PE Score is a validated clinical prediction rule that uses seven weighted clinical variables — including DVT signs, heart rate, recent surgery or immobility, prior VTE history, haemoptysis, malignancy, and clinical gestalt — to estimate the probability that a patient has acute pulmonary embolism. The total score classifies patients as PE unlikely (4 or less) or PE likely (greater than 4), guiding whether D-dimer testing or direct CT pulmonary angiography is the appropriate next step.
What is the difference between the two-level and three-level Wells scoring systems?
The original Wells et al. (2000) paper used a three-level classification: low (<2 points, ~2% PE prevalence), moderate (2–6 points, ~22%), and high (>6 points, ~55%). The simplified two-level system (PE unlikely ≤4, PE likely >4) was validated in the Christopher Study (2006) and is now more widely used because it integrates cleanly with a single D-dimer decision point and has been incorporated into ESC guidelines.
Can a negative D-dimer alone exclude PE?
Only in patients with a low or PE-unlikely pre-test probability. In those with a Wells score of 4 or less, a negative high-sensitivity D-dimer (below the age-adjusted threshold) safely rules out PE with a sensitivity exceeding 98% and a negative predictive value approaching 99.5%. In patients with Wells score >4, D-dimer has no role because even a negative result does not sufficiently lower the probability of PE.
How should the Wells score be interpreted in patients who are already hospitalised?
The Wells score was developed and validated primarily in outpatient and emergency department populations. In hospitalised patients, D-dimer is nearly always elevated due to inflammation, recent surgery, or underlying illness, making it non-informative. In this context, clinical judgment combined with lower-limb venous ultrasound or direct CTPA is typically preferred over the Wells-plus-D-dimer pathway.
What is the age-adjusted D-dimer threshold?
For patients aged 50 and over, the age-adjusted D-dimer threshold is calculated as age (in years) multiplied by 10 mcg/L (using the conventional D-dimer assay). For example, for a 70-year-old patient, the cut-off becomes 700 mcg/L rather than the standard 500 mcg/L. This adjustment reduces unnecessary CTPA by approximately 30% in elderly patients without compromising safety, as validated in the ADJUST-PE study (2014).
Which criterion — 'PE most likely diagnosis' — is the most subjective, and does it reduce reliability?
The 'PE most likely diagnosis' criterion is intentionally subjective and relies on clinical gestalt, which is why it carries 3 points — equal to DVT signs. Studies have shown that this item actually improves the score's discrimination when applied by experienced clinicians. In practice, inter-observer variability on this criterion is the main limitation of the Wells score; however, overall reliability remains acceptable (kappa values typically 0.60–0.72 in published studies).
Is the Wells PE score validated for use in pregnancy?
The Wells score has not been prospectively validated in pregnant women, who are physiologically tachycardic (raising false-positive rates for the HR criterion) and have dramatically elevated D-dimer levels throughout pregnancy, making standard D-dimer thresholds non-applicable. Pregnancy-adapted algorithms such as the modified Geneva score or the YEARS algorithm (with pregnancy-specific D-dimer cut-offs of 1000 mcg/L in the first trimester) are preferred in this population.
What are the limitations of the Wells PE score?
Key limitations include: (1) reliance on subjective gestalt for the highest-weighted criterion; (2) poor performance when applied by non-specialists or in non-emergency settings; (3) reduced utility post-operatively due to elevated D-dimer; (4) lack of validation in pregnancy; (5) the score was derived in populations where prevalence of PE was approximately 25–35%, and its performance may differ in populations with very low or very high prevalence; and (6) it does not distinguish between massive, sub-massive, and incidentally detected PE.
Wskazówka Pro
Use the Wells score and D-dimer as a dyad, never in isolation. In patients with Wells score 4 or less, always order the highest-sensitivity D-dimer your laboratory offers (ELISA-based assays with sensitivity >95% for VTE). If the D-dimer is positive, do not yet pivot to anticoagulation — proceed to CTPA to confirm the diagnosis, localise clot burden, and rule out alternative diagnoses. In patients over 50, apply the age-adjusted D-dimer threshold (age × 10 mcg/L) to avoid over-investigation. Remember: the Wells score stratifies probability; it does not diagnose PE. CTPA remains the gold standard for confirmation.
Czy wiedziałeś?
The Wells PE score was initially derived from a cohort of just 930 patients in a single Canadian centre (Wells et al., 2000), yet it has since been validated in hundreds of thousands of patients across multiple continents and is now used millions of times per year worldwide. The criterion 'PE most likely diagnosis' — which depends entirely on the clinician's intuition — has been shown in meta-analyses to be one of the strongest individual predictors of PE, underscoring that experienced clinical judgement, when formalised into a scoring system, is a powerful diagnostic instrument.
Źródła
- ›Wells PS et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism. Thromb Haemost. 2000;83(3):416-420.
- ›van Belle A et al. (Christopher Study). Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and CT. JAMA. 2006;295(2):172-179.
- ›Konstantinides SV et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41(4):543-603.
- ›Righini M et al. (ADJUST-PE). Age-adjusted D-dimer cut-off levels to rule out pulmonary embolism. JAMA. 2014;311(11):1117-1124.
- ›van der Hulle T et al. (YEARS Study Group). Simplified diagnostic management of suspected pulmonary embolism. Lancet. 2017;390(10091):289-297.